Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the languages menu
  5. Go to the help menu
  6. Go to the modules
  7. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. Canadian Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

Media Room

Contact us

Sanofi Canada

2905 Place Louis-R.-Renaud
Laval, Quebec, H7V 0A3

Media inquiries

514-856-3860
Toll-free: 1-877-904-2667

Catherine Cunningham

Manager, Corporate and
Brand Communications
514-956-6120

General inquiries

514-956-6200
1-800-363-6364

Press Releases

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011

2010200920082007

2007 Archives

Oct 4, 2007
Annual check-up should include waist circumference measurement and assessment of other cardiometabolic risk factors
Sep 4, 2007
Taxotere®-based regimens demonstrated significant superior overall survival over vinca-alkaloid-based regimens in the first-line treatment of advanced non small cell lung cancer
Aug 28, 2007
First and only monthly two-day dosing regimen to treat postmenopausal osteoporosis in Canada
Aug 1, 2007
Plavix® recovers its position in the US, full impact expected in H2
Apr 20, 2007
Risk of having a venous thromboembolism (VTE) is reduced by a significant 43% in acute ischemic stroke patients treated with Clexane®/Lovenox®
Apr 4, 2007
Helping break the silence about prostate cancer
Feb 23, 2007
Long term results confirm the survival benefit of Taxotere®-based treatment in patients with metastatic hormone refractory prostate cancer
 

Corporate information

CORPORATE INFORMATION